Unitedhealth (UNH) EBITDA (2009 - 2026)

Unitedhealth (UNH) has 18 years of EBITDA data on file, last reported at $9.0 billion in Q1 2026.

• On a quarterly basis, EBITDA fell 1.41% year-over-year to $9.0 billion in Q1 2026; TTM through Mar 2026 was $18.8 billion, a 43.73% decrease from a year earlier, with the FY2025 full-year figure at $19.0 billion, down 41.26% from the prior year.
• EBITDA for Q1 2026 stood at $9.0 billion, up from $380.0 million in the prior quarter.
• Over the last five years, EBITDA for UNH reached as high as $9.1 billion in Q1 2025 and fell as low as $380.0 million in Q4 2025.
• Historically, EBITDA has averaged $7.1 billion across 5 years, with a median of $7.8 billion in 2024.
• Across the five-year window, EBITDA jumped 30.64% in 2022 and slumped 95.11% in 2025, its largest moves.
• Year by year, EBITDA stood at $6.9 billion in 2022, then increased by 11.58% to $7.7 billion in 2023, then rose by 1.09% to $7.8 billion in 2024, then slumped by 95.11% to $380.0 million in 2025, then jumped by 2265.79% to $9.0 billion in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $9.0 billion in Q1 2026, $380.0 million in Q4 2025, and $4.3 billion in Q3 2025.